If the cells you would like to access are currently listed as unavailable or you are ordering from outside of Europe please get in touch via Contact@EBiSC.org.

STBCi322-A-7

HNF1A-MODY mutation in STBCi322-A-1 NKX6.1-GFP reporter line.

Gene-edited iPSC line

Not-for-profit fee: £1700 per vial
Not released.
The cell line is not released.
(only basic data is shown)

General#

Cell Line

hPSCreg name STBCi322-A-7
Alternative name(s)
HNF1A-MODY mutation in STBCi322-A-1 NKX6.1-GFP reporter line.
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Notes HNF1A KO in NKX1.6-GFP reporter cell line (STBCi322-A-1)

Provider

Depositor AstraZeneca AB (AZ)
Distributors
EBiSC

External Databases

hPSCreg STBCi322-A-7

General Information

This EBiSC line can be used for:
Yes
Research use: allowed
Clinical use: no
Commercial use: no
Subclone of (not in EBiSC, see STBCi322-A in hPSCreg)

hIPSC Derivation#

General

More source cell information can be found in the parental cell line STBCi322-A in hPSCreg.